BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17932)

  • 1. Sensitization against non-HLA antigens following bone marrow graft rejection.
    Opelz G; Territo MC; Gale RP; Sparkes R
    Tissue Antigens; 1977 Apr; 9(4):209-19. PubMed ID: 17932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies in patients with aplastic anemia who rejected marrow grafts from HLA-identical sibling donors.
    Warren RP; Storb R; Thomas ED
    Transplantation; 1982 Nov; 34(5):280-3. PubMed ID: 6760484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia.
    Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED
    Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.
    Storb R; Prentice RL; Thomas ED
    J Clin Invest; 1977 Apr; 59(4):625-32. PubMed ID: 14972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo detection of alloreactive T cells of host origin after rejection of HLA-identical allogeneic bone marrow transplant].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1525-6. PubMed ID: 3909389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
    Santos GW; Sensenbrenner LL; Anderson PN; Burke PJ; Klein DL; Slavin RE; Schacter B; Borgaonkar DS
    Transplant Proc; 1976 Dec; 8(4):607-10. PubMed ID: 11591
    [No Abstract]   [Full Text] [Related]  

  • 9. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
    Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
    Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
    [No Abstract]   [Full Text] [Related]  

  • 10. Monocytotoxic antibodies after bone marrow transplantation in aplastic anemia.
    Gluckman JC; Gluckman E; Azogui O; Guillet J; Baldwin WM; Devergie A; Chapuis F; Brisson E; Andersen E; Dausset J
    Transplantation; 1982 Jun; 33(6):599-602. PubMed ID: 7048660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia.
    Mickelson EM; Fefer A; Storb R; Thomas ED
    Transplantation; 1976 Sep; 22(3):294-302. PubMed ID: 135386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Bone-marrow grafting for aplastic anaemia.
    Lancet; 1975 Jan; 1(7897):22-3. PubMed ID: 46340
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity against HLA-identical sibling lymphocytes: genetic determination and independent segregation of the antigenic system involved.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):67-9. PubMed ID: 345567
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblings.
    Parkman R; Rosen FS; Rappeport J; Camitta B; Levey RL; Nathan DG
    Transplantation; 1976 Feb; 21(2):110-6. PubMed ID: 129895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia.
    Barrett AJ; Faille A; Saal F; Balitrand N; Gluckman E
    J Clin Pathol; 1978 Dec; 31(12):1244-8. PubMed ID: 372246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow transplantation of aplastic anemia and acute leukemia.
    Thomas ED; Weiden PL
    World J Surg; 1977 Mar; 2(1):197-206. PubMed ID: 17234
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
    Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
    Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.